Florid CD 4+, CD 56+ T cell infiltrate associated with Herpes simplex infection simulating nasal NK/T cell lymphoma
Tadesse-Heath L, Feldman JI, Fahle GA et al. Florid CD 4+, CD 56+ T cell infiltrate associated with Herpes simplex infection simulating nasal NK/T cell lymphoma. Mod Pathol 2003; 16(2):166-72.
Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of P 53 overexpression
Quintanilla L, Franklin JL, Guerrero I et al. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of P 53 overexpression. Human Pathol 1999; 30(7):849-55.
Report of the workshop on nasal and related extra nodal angiocentric T/Natural Killer cell lymphomas
Jaffe ES, Chan JKC, Su IJ et al. Report of the workshop on nasal and related extra nodal angiocentric T/Natural Killer cell lymphomas. Am J Surg Pathol 1996; 20(1):103-11.
Nasal T cell lymphoma associated with Epstein Barr virus. Clinicopathologic, phenotypic and genotypic studies
Harabuchi Y, Imai S, Wakashima J et al. Nasal T cell lymphoma associated with Epstein Barr virus. Clinicopathologic, phenotypic and genotypic studies. Cancer 1996; 77:2137-49.
Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma
Kim BS, Kim TY, Kim CW et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy-result of chemotherapy in NK/T-cell lymphoma. Acta Oncol 2003; 42(7):779-83.
Early stage nasal NK/T cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality
Cheung MMC, Chan JKC, Lau W et al. Early stage nasal NK/T cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 2002; 54(1):182-90.